Clinical Trial Update: Pyrotinib Combined With Dalpiciclib Combined With Letrozole in ER-positive and HER2-positive Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a triple therapy of Pyrotinib, Dalpiciclib, and Letrozole for ER-positive, HER2-positive advanced breast cancer, currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Dalpiciclib (dalpiciclib)
• Letrozole (letrozole)
• Pyrotinib (pyrotinib)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING